Mediti Pharma Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression (NCT03044249) | Mediti Pharma Inc. | 2017-05-04 |
Track Mediti Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.